Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats
The DOI matches its Crossref record.
Abstract
The type-2 (AT 2 ) angiotensin (Ang) II receptor has been characterized as potentially counterregulatory to the actions of Ang II at its type-1 (AT 1 ) receptor. We investigated the effects of Ang II and CGP-42112A (CGP), a selective peptide AT 2 receptor agonist, on blood pressure (BP) in rats with or without pharmacological blockade of the AT 1 receptor with losartan (LOS) or valsartan (VAL). In anesthetized rats (n=5 per group) receiving normal sodium intake, Ang II (200 pmol/kg per minute IV) alone increased BP from a control of 112±3 to 168±7 mm Hg ( P <0.001) and LOS (30 mg/kg) alone decreased BP to 89±7 mm Hg ( P <0.0001 from control). Ang II administered together with LOS decreased BP further to 71±4 mm Hg ( P <0.00001 from control and LOS alone). AT 2 receptor antagonist PD 123,319 (PD) completely blocked the hypotensive response to LOS combined with Ang II ( P =NS from control). In conscious rats (n=5 per group) receiving normal sodium intake, VAL (10 mg/kg) alone decreased BP from a control of 98±5 to 86±3 mm Hg ( P <0.00001). Ang II combined with VAL induced a consistent, highly significant decline in BP for 6 days to a nadir of 69±3 mm Hg ( P <0.01 versus daily VAL alone). PD completely blocked the chronic hypotensive response to the combination of Ang II and VAL to control levels before VAL administration. In another study in conscious rats (n=5 per group), CGP (70 μg/kg per minute) also decreased BP in VAL-treated conscious rats. BP was 119±3 mm Hg during the control period, decreased to 86±6 mm Hg during 3 days of VAL alone, ( P <0.00001) and decreased further to 65±7 mm Hg ( P <0.001 from daily VAL alone) with 7 days of CGP in the presence of VAL. In the absence of VAL, CGP decreased BP for 4 consecutive days, and this response was blocked by PD. Also, the CGP-induced decrease in BP over a 7-day period was blocked by N G -nitro- l -arginine methyl ester, an inhibitor of NO synthase. The results strongly suggest that the AT 2 receptor induces a systemic vasodilator response mediated by NO that counterbalances the vasoconstrictor action of Ang II at the AT 1 receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Self-citationDesign, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist
Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlén, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049715t · Cited by 330
SCHIFFRIN, E. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.023 · Cited by 327
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Castrop, H., Höcherl, K., Kurtz, A., Schweda, F., Todorov, V., & Wagner, C. (2010) · Physiological Reviews · doi:10.1152/physrev.00011.2009 · Cited by 269
AT2 receptors: Functional relevance in cardiovascular disease
Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.009 · Cited by 237
“Using this approach, selective stimulation of AT2R by CGP42112 lowered BP, provided that there was a background of AT1R blockade in conscious rats (Barber et al., 1999; Carey et al., 2001).”
BackgroundAngiotensin AT2 receptors: cardiovascular hope or hype?
Widdop, R. E., Jones, E. S., Hannan, R. E., & Gaspari, T. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705448 · Cited by 223
“Furthermore, valsartan reduced SBP in sodium- depleted rats and renal-dependent hypertensive rats, and this effect of valsartan was blocked by a 30-min coinfusion of the AT2R antagonist PD123319 (Siragy & Carey, 1999; Siragy et al., 2000), although this ‘PD123319 reversal’ has not always been seen in studies by the sa…”
BackgroundMethodInfluentialAngiotensin II Type 2 Receptor–Mediated Vasodilation in Human Coronary Microarteries
Batenburg, W. W., Garrelds, I. M., Bernasconi, C. C., Juillerat-Jeanneret, L., van Kats, J. P., Saxena, P. R., & Danser, A. H. J. (2004) · Circulation · doi:10.1161/01.cir.0000128696.12245.57 · Cited by 199
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Schmaier, A. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00535.2002 · Cited by 167
“In rats, AT2 receptor stimulation induces a systemic vasodilator response mediated by BK and NO that counterbalances the vasoconstrictor action of ANG II at the AT1 receptor (19).”
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Cosarderelioglu, C., Nidadavolu, L. S., George, C. J., Oh, E. S., Bennett, D. A., Walston, J. D., & Abadir, P. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586314 · Cited by 134
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Self-citationSampson, A. K., Hilliard, L. M., Moritz, K. M., Thomas, M. C., Tikellis, C., Widdop, R. E., & Denton, K. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00256.2011 · Cited by 75
“Previously, we have demonstrated that the reduction in arterial pressure in response to low-dose ANG II infusion was abolished by AT2R blockade and thus mediated by the AT2R (30), consistent with the well-recognized role of AT2R in vasodilation, countering the AT1R-mediated vasoconstriction (3, 5, 9, 11, 19, 42).”
BackgroundThe frail renin–angiotensin system
Abadir, P. M. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.08.004 · Cited by 70
Metadata
- Authors
- Carey, R. M., Howell, N. L., Jin, X.-H., & Siragy, H. M.
- Venue
- Hypertension
- Published
- 2001-12
- Volume
- 38
- Issue
- 6
- Pages
- 1272-1277
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2119534102
- Cited by
- 147
- References
- 0
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.